VistaGen Therapeutics, Inc.
VTGN
$0.70
$0.0913.85%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 13.89% | 2.67% | -28.63% | -10.71% | 3.22% |
| Total Depreciation and Amortization | 0.53% | 2.16% | 9.47% | 1.81% | 3.11% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -20.57% | 0.32% | 19.65% | -4.91% | -14.62% |
| Change in Net Operating Assets | -792.86% | -97.21% | 195.95% | -283.28% | -3.67% |
| Cash from Operations | 8.12% | -28.14% | 26.99% | -87.30% | 2.12% |
| Capital Expenditure | 100.00% | 56.67% | 7.69% | 26.14% | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -176.15% | 482.35% | 95.30% | -217.56% | 245.73% |
| Cash from Investing | -195.19% | 210.64% | 88.07% | -249.53% | 224.88% |
| Total Debt Issued | -- | -- | -100.00% | -- | -- |
| Total Debt Repaid | -1.80% | -1.46% | -204.44% | -- | -- |
| Issuance of Common Stock | -100.00% | -91.44% | 4,905.02% | -71.40% | 66.61% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -113.40% | -92.36% | 1,758.47% | -23.73% | 66.61% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -7.57% | -211.69% | 176.06% | -139.27% | 20.43% |